NMDAE trials for Schizophrenia

All NMDAE trials · All Schizophrenia trials

Phase breakdown

Recruiting trials studying NMDAE for Schizophrenia

• Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
  NCT05052853 · Phase: Phase 2 · Ages: 13 Years to 45 Years · Sex: All (male and female) · 1 location
• Monotherapy of an NMDA Enhancer for Schizophrenia
  NCT04745143 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
  NCT06021197 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Sex Differences in NMDA-enhancing Treatment of Schizophrenia
  NCT07122895 · Phase: Phase 2 · Ages: 20 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study NMDAE for Schizophrenia?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.